|Articles|December 1, 2002
- Pharmaceutical Executive-12-01-2002
Table of Contents (December 2002)
Table of Contents
Advertisement
Articles in this issue
about 23 years ago
The Pain Pipelineabout 23 years ago
FDA in Motionabout 23 years ago
Every Employee, Every Dayabout 23 years ago
The Geometry of RiskNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Trending on PharmExec
1
Report: Richard Pazdur Out as Director of CDER
2
Pharmaceutical Commercialization: A 2026 Outlook Personalization and Precision Will Define a New Year in Pharma
3
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
4
Regeneron Announces $150 Million Collaboration with Tessera Therapeutics to Develop Gene Editing Therapy
5
